Laipẹ, Nantong Chanyoo ti ṣe iṣẹlẹ pataki miiran ninu itan-akọọlẹ!Pẹlu awọn akitiyan fun ọdun diẹ sii, KDMF akọkọ ti Chanyoo ti ni ifọwọsi nipasẹ MFDS.Gẹgẹbi olupese ti o tobi julọ ti Calcium Rosuvastatin ni Ilu China,a fẹ lati ṣii ipin tuntun ni ọja Koria.Ati pe awọn ọja diẹ sii yoo ṣe ifilọlẹ ni awọn ọdun diẹ to nbọ.

Paapaa, o le tọka ki o wa alaye wa lati oju opo wẹẹbu yii:

https://nedrug.mfds.go.kr/pbp/CCBAC03

kalisiomu Rosuvastatin dara fun itọju adjuvant ti awọn alaisan ti o ni hypercholesterolemia akọkọ (iru IIa, pẹlu heterozygous familial hypercholesterolemia) tabi lipemia ti o dapọ (iru IIb) nigbati ounjẹ tabi adaṣe adaṣe ko dara.kalisiomu rosuvastatinjẹ oludena reductase 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) yiyan.Nipa idinamọ HMG-CoA reductase, o dinku iṣelọpọ sẹẹli ẹdọ ati ibi ipamọ ti idaabobo awọ, nitorinaa Isalẹ ẹjẹ lapapọ idaabobo awọ (TC) ati awọn ipele idaabobo awọ lipoprotein iwuwo kekere (LDL-C).

Gẹgẹbi data Newport, lati Oṣu Karun ọjọ 30, ọdun 2018 si Oṣu Karun ọjọ 30, 2019, awọn tita agbaye ti awọn igbaradi kalisiomu rosuvastatin jẹ bilionu US $ 3.461, idinku ọdun kan ti 13%;Titaja agbaye ti awọn ohun elo aise ti kalisiomu rosuvastatin jẹ 151.09 toonu, ilosoke ọdun kan ti 14%

Awa,Ile-iṣẹ elegbogi Changzhou(olupese oniranlọwọ: Nantong Chanyoo Pharmatech Co., Ltd.) fi ara wa fun olupese ti o tobi julọ ti Rosuvastatin API.